Transcription factors in the pathogenesis of pulmonary arterial hypertension-Current knowledge and therapeutic potential.
Ontology highlight
ABSTRACT: Pulmonary arterial hypertension (PAH) is a disease characterized by elevated pulmonary vascular resistance and pulmonary artery pressure. Mortality remains high in severe cases despite significant advances in management and pharmacotherapy. Since currently approved PAH therapies are unable to significantly reverse pathological vessel remodeling, novel disease-modifying, targeted therapeutics are needed. Pathogenetically, PAH is characterized by vessel wall cell dysfunction with consecutive remodeling of the pulmonary vasculature and the right heart. Transcription factors (TFs) regulate the process of transcribing DNA into RNA and, in the pulmonary circulation, control the response of pulmonary vascular cells to macro- and microenvironmental stimuli. Often, TFs form complex protein interact
SUBMITTER: Korbelin J
PROVIDER: S-EPMC9853303 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA